Showing results (261-270 of 276) with videos related to
Sort By:
Pageof 28
Journal of the American Chemical Society|December 26, 2024
Synergistic Ultrasound-Activable Artificial Enzyme and Precision Gene Therapy to Suppress Redox Homeostasis and Malignant Phenotypes for Controllably Combating Hepatocellular CarcinomaYinghao Lyu, Qian Li, Sinan Xie, et al.Plos One|March 13, 2010
Discovery of novel microRNAs in female reproductive tract using next generation sequencingChad J Creighton, Ashley L Benham, Huifeng Zhu, et al.Gut|March 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiencyXiaochuan Dong, Shumei Song, Yuan Li, et al.Thyroid : Official Journal of the American Thyroid Association|July 23, 2019
Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid CarcinomaXiao Shi, Peng-Cheng Yu, Bo-Wen Lei, et al.Molecular Cancer|October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu, Yuan Li, Jiankang Jin, et al.Journal of Experimental & Clinical Cancer Research : CR|June 24, 2021
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinomaShumei Song, Yan Xu, Longfei Huo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.Journal of Experimental & Clinical Cancer Research : CR|August 22, 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinomaYuan Li, Yibo Fan, Jinbang Xu, et al.Gut|January 25, 2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinomaShumei Song, Qiongrong Chen, Yuan Li, et al.British Journal of Cancer|November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitorsJaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.Pageof 28